Steve Greenway

Company: Vesigen Therapeutics

Job title: Director Upstream Process Development

Seminars:

Looking into the Future: Moving Towards Non-Viral Gene Therapies 10:00 am

Overview of Vesigen Therapeutics’ ARMMS technology as a novel modality for non-viral delivery of therapeutics Managing scalable upstream production of ARMMs using transient transfection or stable producer cell lines Exploring the advantages of ARMMs as a delivery platform for gene therapiesRead more

day: Conference Day Two